Low invasive therapy with gratnilotyte colony stimulating factor in patients with coronary artery dicease
Low invasive therapy with gratnilotyte colony stimulating factor in patients with coronary artery dicease
批准号:
18590765
负责人:
MINATOGUCHI Shinya
金额:
$2.49万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
1)在患有急性心肌梗塞的患者中,在心肌梗塞后1个月用2-5 mg/kg剂量的G-CSF皮下治疗显著改善了射血分数,这通过左心室造影来评估(Suzuki K,et. 2)兔经历30分钟的冠状动脉闭塞,随后再灌注48小时,在缺血前10分钟静脉内施用普伐他汀(1或5 mg/kg)或盐水。再灌注前10 min给予普伐他汀5 mg/kg。在注射普伐他汀前10 min分别静脉注射L-NAME(10 mg/kg)、白屈菜红碱(5 mg/kg)或5-HD(5 mg/kg)。测定梗死面积。测定心肌间质中2,5-DHBA和NOx的含量及心肌二氢乙锭染色强度。与对照组(45±3%)相比,缺血前普伐他汀治疗(1和5 mg/kg)分别减少了梗死面积(34±5%和24± 4%),但再灌注前治疗(42.1±3.7%)没有减少。L-NAME、白屈菜红碱和5-HD可分别阻断上述作用(42.6±4%、50.9±3%和52.7±2%)。缺血前用普伐他汀治疗增加心肌NOx水平,并减弱再灌注期间2,5-DHBA水平和二氢乙锭染色强度。白屈菜红碱消除了普伐他汀引起的NOx水平升高。缺血前用普伐他汀治疗通过蛋白激酶C依赖的一氧化氮产生、减少羟基自由基和超氧化物以及开放线粒体KATP通道来减少心肌梗死面积。
英文摘要
1) In patients with acute myocardial infarction, subcutaneous treatment with G-CSF at a dose of 2-5 mg/kg significantly improved ejection fraction at 1 months after myocardial infarction assacsed by left ventriculogram (Suzuki K, et. al. Circ J 2006)2) Rabbits underwent 30 min of coronary occlusion followed by 48 hours of reperfusion Pravastatin (1 or 5mg/kg) or saline was intravenously administered 10 min before ischemia. Pravastatin (5mg/kg) was also administered 10 min before reperfusion. L-NAME (10mg/kg), chelerythrine (5mg/kg) or 5-HD (5mg/kg) was i.v. administered 10 min before pravastatin injection. The infarct size was determined. The myocardial interstitial levels of 2, 5-DHBA and NOx, and the intensity of myocardial dihydroethidium staining were obtained. Pre-ischemic treatment with pravastatin reduced the infarct size (34±5% and 24±4%, 1 and 5mg/kg, respectively) but not pre-reperfusion treatment (42.1±3.7%) compared with the control (45±3%). This effect was blocked by L-NAME (42.6±4%), chelerythrine (50.9±3%) and 5-HD (52.7±2%), respectively. Pre-ischemic treatment with pravastatin increased myocardial NOx levels and attenuated the 2,5-DHBA levels and the intensity of dihydroethidium staining during reperfusion. Chelerythrine abolished the increase in NOx levels by pravastatin. Pre-ischemic treatment with pravastatin reduces the myocardial infarct size via protein kinase C-dependent nitric oxide production, decreasing hydroxyl radicals and superoxide, and opening the mitochondrial KATP channels.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A low dose but long duration post-myocardial infarction treatment with granulocyte colony-stimulating factor shows a beneficial effect without any complications
心肌梗塞后用粒细胞集落刺激因子进行低剂量但持续时间长的治疗显示出有益的效果,且没有任何并发症
DOI:
--
发表时间:
2008
期刊:
影响因子:
--
作者:
[Minatoguchi S, et. al.]
通讯作者:
et. al.
DOI:
10.1253/circj.70.430
发表时间:
2006-04-01
期刊:
CIRCULATION JOURNAL
影响因子:
3.3
作者:
[Suzuki, K, Nagashima, K, Fujiwara, H]
通讯作者:
Fujiwara, H
DOI:
10.1253/circj.71.1622
发表时间:
2007-10-01
期刊:
CIRCULATION JOURNAL
影响因子:
3.3
作者:
[Bao, Narentuoya, Minatoguchi, Shinya, Fujiwara, Hisayoshi]
通讯作者:
Fujiwara, Hisayoshi
A new mechanisms of G-CSF effect against myocardial infarction - molecular mechanism of healing process acceleration -
-
批准号:16590670
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2004
-
负责人:MINATOGUCHI Shinya
-
依托单位:
Soluble Fas, an inhibitor of apoptosis, gene therapy using adenovirus vector for ischemia-reperfusion injury
-
批准号:13670699
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2001
-
负责人:MINATOGUCHI Shinya
-
依托单位:
Investigation of mechanism of infarct size-reducing effect of α-1,6-glucosidase inhibitor
-
批准号:10670639
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:1998
-
负责人:MINATOGUCHI Shinya
-
依托单位:
ROLE OF ENDOTHELIUM DERIVED RELAXING FACTOR IN THE REGULATION OF THE TONE OF THE VENOUS SYSTEM
-
批准号:05670601
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.15万
-
财政年份:1993
-
负责人:MINATOGUCHI Shinya
-
依托单位:
海外基金